Adapting Group Prenatal Care for Telehealth: A COVID‐Era Innovation to Address Barriers to Care for Latinx Clients
Journal of Midwifery & Women's Health · 2024
DOI: 10.1111/jmwh.13701 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Midwifery & Women's Health, 2024. Verfasst von Catherine Daily und 3 weiteren Autor:innen. Beteiligte Einrichtung: Georgetown University School of Nursing, Washington, District of Columbia. Hauptthemen laut MEDLINE: Health Services Accessibility, Hispanic or Latino, Prenatal Care, Telemedicine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences of the National Institutes of Health.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
The use of telehealth prenatal care increased exponentially during the coronavirus disease 2019 (COVID‐19) pandemic, but there is no literature describing its use for group prenatal care during this time. The COVID‐19 pandemic also exacerbated structural barriers to care that disproportionately affect Black and Latinx people. Telehealth enabled pregnant people to access health care and minimize infectious risks. Telehealth group prenatal care (T‐GPNC) incorporated the essential elements of CenteringPregnancy with telehealth is an innovative care delivery method borne out of necessity during the COVID‐19 pandemic that has potential to mitigate structural barriers to care. Mary's Center is a federally qualified health center (FQHC) in Washington, DC, and Maryland that rapidly pivoted to individual telehealth prenatal care early in the pandemic. Mary's Center used our experience with group care and guidance from the Centering Healthcare Institute on virtual Centering to launch T‐GPNC. This new model included home self‐monitoring equipment and video classrooms, mixed with in‐person individual care visits. We used a team‐based approach with nurses, midwives, and community health workers to provide holistic care to pregnant people. Our robust care coordination team also connected them to home visiting, mental health services, and nutrition counseling. The purpose of this article is to describe how Mary's Center modified the CenteringPregnancy model of group prenatal care for telehealth, following the hallmarks of CenteringPregnancy, and met the needs of Spanish‐speaking clients, henceforth Latinx clients. A secondary purpose is to demonstrate how telehealth can expand access to health care and remove structural barriers that may prevent pregnant people from attending in‐person appointments. We also discuss the structural inequities in digital access and literacy in the context of program implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Georgetown University School of Nursing, Washington, District of Columbia.
- Mary's Center, Washington, District of Columbia.
- Johns Hopkins University School of Nursing, Baltimore, Maryland.
ORCID-Profile: Catherine Daily, Ashley Gresh, Christina X Marea
Förderung
- NCATS NIH HHS
- National Center for Advancing Translational Sciences of the National Institutes of Health
Zitieren
APA
Daily, C., Gresh, A., Hamilton, E. R., & Marea, C. X. (2024). Adapting Group Prenatal Care for Telehealth: A COVID‐Era Innovation to Address Barriers to Care for Latinx Clients. Journal of Midwifery & Women's Health. https://doi.org/10.1111/jmwh.13701
Vancouver
Daily C, Gresh A, Hamilton ER, Marea CX. Adapting Group Prenatal Care for Telehealth: A COVID‐Era Innovation to Address Barriers to Care for Latinx Clients. Journal of Midwifery & Women's Health. 2024. doi:10.1111/jmwh.13701
BibTeX
@article{Daily2024,
author = {Daily, Catherine and Gresh, Ashley and Hamilton, Elizabeth R and Marea, Christina X},
title = {Adapting Group Prenatal Care for Telehealth: A COVID‐Era Innovation to Address Barriers to Care for Latinx Clients},
journal = {Journal of Midwifery & Women's Health},
year = {2024},
doi = {10.1111/jmwh.13701}
}
EUVIMED